Company News: Sanofi-Aventis, Chattem, Allergan and Pacific Communications

Share this article:
Sanofi-Aventis completed its acquisition of Chattem, strengthening its presence in the US consumer healthcare market and bolstering its OTC switch capabilities. Chattanooga, TN-based Chattem will continue to be led by Zan Guerry, CEO, who will report to Sanofi-Aventis US president and CEO Greg Irace.
 
Allergan
named Pacific Communications agency of record for overactive bladder treatment Sanctura XR. The review resulted from a co-promotion agreement Allergan entered into with Quintiles whereby Quintiles will leverage its expertise in primary care to rapidly deploy a specialized sales for ce for the product while Allergan continues to target urology. Pacific will act as agency of record on both efforts.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.